Balyasny Asset Management »

Design Therapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Design Therapeutics (DSGN) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Design Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Design Therapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Design Therapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2023-06-30 $117k 19k 6.30
2022-09-30 $186k 11k 16.71
2021-03-31 $1.3M 43k 29.90

More positions owned by Balyasny Asset Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Tesla Motors Call Option (TSLA)
Select Sector Spdr Tr Financial (XLF)
Amazon Call Option (AMZN)
Meta Platforms Cl A Call Option (META)
Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vaneck Etf Trust Gold Miners Etf (GDX)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Visa Com Cl A Call Option (V)
Wolfspeed Common Stock (WOLF)

View all positions for Balyasny Asset Management

Top funds holding Design Therapeutics

Sr One Capital Management
Logos Global Management
Point72 Asset Management
BlackRock
Frazier Life Sciences Management
Tang Capital Management
Baker Bros. Advisors
Vanguard Group
Almitas Capital
Driehaus Capital Management
Kynam Capital Management
FMR
Geode Capital Management
State Street Corporation
Acadian Asset Management

View all funds holding Design Therapeutics